Nebius Stock Tripled in 2025. Is There More Growth Ahead in 2026?

Nebius reported Q2 sales of $105 million and a 2025 surge driven by two hyperscaler deals — a September agreement with Microsoft valued up to $19.4 billion and a November five‑year arrangement with Meta worth about $3 billion — which has sold out its available data center capacity and pushed the stock up 202.2% year‑to‑date. Management raised guidance toward an annual revenue run rate of up to $1.1 billion by end‑2025 and is targeting a materially higher run rate (guidance midpoint cited at ~$8 billion) thereafter, while the company is also expanding into AI data services (Toloka), edtech, and autonomous delivery (Avride). The developments materially improve top‑line trajectory but leave significant execution risk — investors have largely priced in aggressive growth, so any slowdown in AI cloud demand or delivery could sharply affect the valuation.

Analysis

Market structure: Nebius (NBIS) winning hyperscaler OEMs (MSFT, META) get immediate demand certainty — NBIS gains pricing power for specialized AI racks while GPU suppliers (NVDA) and power/utility suppliers also benefit from higher utilization. Traditional colocation REITs (EQIX, DLR) face margin pressure on premium AI workloads and will be forced to niche or undercut pricing; expect a 5–15% spread compression in commoditized colo services over 12–24 months.

Risk assessment: Key tail risks are contract rescindment or delayed GPU supply (Nvidia export/regulatory shocks), execution/capex overruns, and customer concentration (if MSFT+META >50% of 2026 revenue). Immediate (days) risk = headline volatility around deliveries; short-term (3–6 months) risk = shipment & installation cadence; long-term (2–3 years) risk = vertical integration by hyperscalers reducing third-party addressable market.

Trade implications: Tactical direct play = small, option-backed exposure to NBIS (caps downside) and levered long exposure to NVDA for GPU cyclical upside; underweight/short selective colo REITs (EQIX, DLR). Use 6–12 month call spreads on NBIS to capture re-rating while limiting capital at risk; buy 6–12 month NVDA calls (or 1–2% outright long) to capture further GPU-driven upside.

Contrarian angles: Consensus prices execution as given — miss that and downside is sharp (set 20% stop on equity). Conversely, market may underprice Avride/Toloka optionality: if either contributes >5% revenue by 2027, upside rerating could be 30–50%. Historical parallel: CoreWeave’s re-rating after hyperscaler deals supports asymmetric long via structured options, but vertical integration remains the biggest structural risk.

Key Decisions for Investors

• Establish a limited exposure to NBIS sized 2–3% of portfolio via a 12-month call spread (buy ATM, sell 30–40% OTM) to capture upside from announced MSFT/META contracts while capping downside; re-evaluate after next quarterly report (within 30–60 days).
• Allocate 1–2% portfolio long NVDA (or buy 6–12 month calls) to play GPU demand tailwind; if NVDA outperforms >25% in 90 days, trim to 1% and rotate profits into NBIS call positions.
• Short selective traditional colo REITs (EQIX or DLR) via 3–6 month put purchases or small outright shorts equal to 1–2% NAV, anticipating 5–15% margin contraction in commoditized rack offerings over 12–24 months; cover if NBIS revenue concentration falls below 40% or if sector sentiment reverses.
• Set hard risk rules: cut NBIS equity exposure by 50% if quarterly bookings miss guidance by >15% or if MSFT+META expected share of 2026 revenue exceeds 60%; take profits if NBIS shares double from entry or implied ARR confirmation reaches >=$8B with audited bookings.